Patients with active LN had substantially higher urinary concentrations of ALCAM, KIM-1, PF4, and VCAM-1 than to those with active non-renal SLE, inactive SLE, and healthy controls. This evidence concerns the gene ALCAM and systemic lupus erythematosus.